Drug-versus-Drug Adverse Event Rate Comparisons: A Pilot Study Based on Data from the US FDA Adverse Event Reporting System

By Hochberg Alan M.   Pearson Ronald K.   O'Hara Donald J.   Reisinger Stephanie J.  

Drug Safety, Vol. 32, Iss. 2, 2009-01 ,pp. : 137-146

Adis International

Access to resources Recommend Favorite

Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System: Disposition of Events Identified and Impact on Product Safety Profiles

By Bailey Steven   Singh Ajay   Azadian Robert   Huber Peter   Blum Michael  

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

Data Mining in the US using the Vaccine Adverse Event Reporting System

By Iskander John  

Drug Safety, Vol. 29, Iss. 5, 2006-01 ,pp. : 375-384

Adis International

Access to resources Recommend Favorite

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei  

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite

Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS)

By Emily Jane Woo   Ball Robert   Burwen Dale R.   Braun M. Miles  

Drug Safety, Vol. 31, Iss. 8, 2008-01 ,pp. : 667-674

Adis International

Access to resources Recommend Favorite